FindTrial
Sign In

A Study of oral vs vaginal natural micronized progesterone in management of preterm labour.

Comparative study of oral vs vaginal natural micronized progesterone in management of preterm labour - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090226
Enrollment
100
Registered
2025-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O601- Preterm labor with preterm delivery Health Condition 2: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: Oral natural micronized progesterone 200 mg 12 hourly versus vaginal natural micronized progesterone 200 mg 12 hourly till 37 weeks of pregnancy in preventing preterm labour.: 50 antena

Sponsors

Dr kriti vardani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women aged eighteen to forty years. History of spontaneous preterm birth. Live singleton pregnancy.

Exclusion criteria

Exclusion criteria: Allergic to progesterone therapy. Refusal of patient to provide informed written consent. Known fetal anomalies. Multiple pregnancy. Prior progesterone treatment during current pregnancy. Suspected chorioamnionitis. Intrauterine fetal demise.

Design outcomes

Primary

MeasureTime frame
Number of patients who landed up in preterm labour.Timepoint: At 37 weeks , 40 weeks—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Kiran Dabholkar

Varun Arjun medical college and rohilkhand hospital banthra Shahjahanpur

explain4you@gmail.com9167008017

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026